Macroamylasemia

IMacroamylasemia ubukhona bento engajwayelekile ebizwa nge-macroamylase egazini.

IMacroamylase yinto equkethe i-enzyme, ebizwa nge-amylase, enamathiselwe kuphrotheni. Ngenxa yokuthi inkulu, i-macroamylase ihlungwa kancane kakhulu egazini izinso.

Iningi labantu abane-macroamylasemia abanaso isifo esibi esisibangelayo, kepha isimo sihlotshaniswa ne:

• Isifo seCeliac
• I-Lymphoma
• Ukutheleleka nge-HIV
• I-gammopathy ye-Monoclonal
• Isifo samathambo
• I-ulcerative colitis

IMacroamylasemia ayizibangeli izimpawu.

Ukuhlolwa kwegazi kuzobonisa amazinga aphezulu e-amylase. Kodwa-ke, i-macroamylasemia ingabukeka ifana ne-pancreatitis ebukhali, nayo edala amazinga aphezulu e-amylase egazini.

Ukukala amazinga e-amylase emchameni kungasiza ukutshela i-macroamylasemia ngaphandle kwe-pancreatitis enamandla. Izinga le-urine le-amylase liphansi kubantu abane-macroamylasemia, kodwa liphezulu kubantu abane-pancreatitis enamandla.

UFrasca JD, uVelez MJ. I-pancreatitis enamandla. Ku: Parsons PE, Wiener-Kronish JP, Stapleton RD, Berra L, ama-eds. Izimfihlo Zokunakekelwa Okubucayi. Umhlaka 6. IPhiladelphia, PA: Elsevier; 2019: isahluko 52.

USiddiqi HA, uSalwen MJ, uShaikh MF, uBowne WB. Ukuxilongwa kwelabhoratri kokuphazamiseka kwamathumbu kanye ne-pancreatic. Ku: McPherson RA, Pincus MR, abahleli. UHenry’s Clinical Diagnosis and Management by Laboratory Methods. Umhla ka-23. ISt Louis, MO: Elsevier; I-2017: isahluko 22.

I-Tenner S, iSteinberg WM. I-pancreatitis enamandla. Ku: Feldman M, Friedman LS, Brandt LJ, ama-eds. ISleisenger neFordtran's Gastrointestinal and Liver Disease: IPathophysiology / Diagnosis / Management. Umhlaka 10. IPhiladelphia, PA: Elsevier Saunders; 2016: isahluko 58.